BZI-ROCE

According to Benzinga Pro data, during Q1, Tutor Perini (NYSE:TPC) posted sales of $776.30 million. Earnings were up 44.19%, but Tutor Perini still reported an overall loss of $48.93 million. In Q4, Tutor Perini brought in $906.65 million in sales but lost $87.67 million in earnings. What Is...

Pulled from Benzinga Pro data, Willdan Group (NASDAQ:WLDN) posted Q1 earnings of $932 thousand, an increase from Q4 of 319.29%. Sales dropped to $61.69 million, a 4.45% decrease between quarters. In Q4, Willdan Group brought in $64.56 million in sales but lost $425 thousand in earnings. What Is...

DermTech (NASDAQ:DMTK) brought in sales totaling $3.48 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 10.8%, resulting in a loss of $31.27 million. DermTech collected $2.99 million in revenue during Q4, but reported earnings showed a $28.22 million loss....

Benzinga Pro data, Arteris (NASDAQ:AIP) reported Q1 sales of $13.15 million. Earnings fell to a loss of $9.01 million, resulting in a 24.88% decrease from last quarter. Arteris collected $11.20 million in revenue during Q4, but reported earnings showed a $7.21 million loss. What Is ROCE? Return...

Benzinga Pro data, OneSpan (NASDAQ:OSPN) reported Q1 sales of $57.61 million. Earnings fell to a loss of $8.36 million, resulting in a 169.81% decrease from last quarter. In Q4, OneSpan brought in $56.62 million in sales but lost $3.10 million in earnings. Why Is ROCE Significant? Return on...

Benzinga Pro data, iSpecimen (NASDAQ:ISPC) reported Q1 sales of $2.95 million. Earnings fell to a loss of $2.43 million, resulting in a 12.6% decrease from last quarter. iSpecimen collected $2.96 million in revenue during Q4, but reported earnings showed a $2.16 million loss. What Is Return On...

According to Benzinga Pro data, during Q1, C4 Therapeutics (NASDAQ:CCCC) posted sales of $3.76 million. Earnings were up 6.47%, but C4 Therapeutics still reported an overall loss of $34.78 million. In Q4, C4 Therapeutics brought in $2.85 million in sales but lost $37.19 million in earnings. What...

According to Benzinga Pro, during Q1, InterDigital (NASDAQ:IDCC) earned $103.52 million, a 223.44% increase from the preceding quarter. InterDigital also posted a total of $202.37 million in sales, a 72.89% increase since Q4. InterDigital earned $32.01 million, and sales totaled $117.06 million in...

Benzinga Pro data, Itron (NASDAQ:ITRI) reported Q1 sales of $494.62 million. Earnings fell to a loss of $12.04 million, resulting in a 154.84% decrease from last quarter. In Q4, Itron earned $21.95 million and total sales reached $467.49 million. Why Is ROCE Significant? Return on Capital...

According to data from Benzinga Pro, during Q1, Karyopharm Therapeutics's (NASDAQ:KPTI) reported sales totaled $38.70 million. Despite a 11.37% increase in earnings, the company posted a loss of $34.13 million. In Q4, Karyopharm Therapeutics brought in $33.58 million in sales but lost $38.51...

Lee Enterprises (NASDAQ:LEE) brought in sales totaling $170.69 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 394.19%, resulting in a loss of $5.37 million. Lee Enterprises earned $1.82 million, and sales totaled $185.13 million in Q1. What Is ROCE? Return...

NovoCure (NASDAQ:NVCR) brought in sales totaling $122.18 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 42.24%, resulting in a loss of $53.06 million. In Q4, NovoCure brought in $128.43 million in sales but lost $37.30 million in earnings. What Is Return...

Pulled from Benzinga Pro data, Ducommun (NYSE:DCO) posted Q1 earnings of $5.23 million, an increase from Q4 of 35.27%. Sales dropped to $181.19 million, a 3.76% decrease between quarters. In Q4, Ducommun earned $8.08 million, and total sales reached $188.27 million. What Is Return On Capital...

According to Benzinga Pro, during Q1, Walker & Dunlop (NYSE:WD) earned $27.47 million, a 27.01% increase from the preceding quarter. Walker & Dunlop's sales decreased to $238.75 million, a 15.59% change since Q4. In Q4, Walker & Dunlop earned $37.63 million, and total sales reached $282...

Aurinia Pharmaceuticals (NASDAQ:AUPH) brought in sales totaling $34.41 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 0.61%, resulting in a loss of $26.21 million. Aurinia Pharmaceuticals collected $28.43 million in revenue during Q4, but reported earnings...